Progress in Outreach Sample Clauses

Progress in Outreach. The University subscribes to the Higher Education Access Tracker collaborative service which enables us to track most participants in more intensive elements of our programme through to higher education. Results demonstrate the effectiveness of our sustained outreach programmes with target schools and targeted participants. • Over the 9 years from 2007/8 to 2015/16 the average HE participation rate of The University of Winchester’s tracked cohort, aged 18 years only (worked out in accordance with the HEFCE YPR), and who were eligible to progress to HE, was 35%. This compares with a HEFCE national YPR of 38% in 2011/12. Additionally, 40% of those tracked in the same period appeared in the HE population at some stage. Given the profile of the students in the tracked cohort of 8379 outreach participants (61% from the most deprived POLAR3 quintiles, 57% meeting at least one indicator of deprivation, and 64% declaring themselves as first generation HE), this is a measure of the success of widening participation programmes implemented by the University of Winchester. • Furthermore, over the 9 years from 2007/08 to 2015/16 the average young participation rate of Winchester’s tracked cohort from POLAR3 quintiles 1 and 2 was 31%. This compares with a national rate of 25% and a Hampshire rate of 20.6% in 2014/15. • Of those in The University of Winchester's tracked cohort, who were ready to progress to HE between 2007/08 and 2013/14, and have achieved a First Degree, 74% achieved a First Class or Upper Second Class Degree. This compares with the national average of 70%, including the most advantaged students in the country. • 2014/15 - 80% of The University of Winchester's tracked participants who were classified in the lowest NS-SEC (groups 4-8) on entry to HE (taken from parental occupation), moved into the higher socio-economic groups 1-3 after leaving HE, based on their occupation six months after graduation. We survey participants to gather quantitative and qualitative data and an illustration of results for 2015-16 is given below: • Overall 85% of secondary school participants and 69% of primary school participants in intensive outreach met at least one WP criterion. 48% of intensive outreach participants were male. 62% of participants in on-campus outreach were from POLAR Q1-2. Of participants from POLAR Q3-5, 20% were first generation HE, 10% were disabled, 5% were in care, 4% were young carers, 3% were from military families, and 11% were BME. • Primary sch...
Sample 1
AutoNDA by SimpleDocs

Related to Progress in Outreach

  • Outreach Not less than 30 days prior to the opening of bids or the selection of contractors, the Agency-Assisted Contractor or Contractor shall:

  • Public Outreach The Sponsor is responsible for development and administration of a public outreach effort to ensure public awareness and involvement in the Project development and delivery process. The Sponsor shall provide a copy of the public outreach plan and all materials documenting the public outreach activities, including public notices, press releases, flyers, etc. to the Authority. The public outreach plan must accompany the first invoice for payment from Sponsor. The materials documenting the public outreach activities must accompany the final invoice for payment from Sponsor.

  • Community Outreach Please describe all community outreach efforts undertaken since the last report.

  • DEVELOPMENT OR ASSISTANCE IN DEVELOPMENT OF SPECIFICATIONS REQUIREMENTS/ STATEMENTS OF WORK

  • Outreach Activities a. The Agency shall conduct outreach activities for potential Clients to promote the availability of services. b. Outreach activities shall include, but are not limited to, participation in health fairs, community events, collaboration with other providers, and the posting of flyers for potential Clients. c. The Agency shall have an outreach plan and shall provide evidence of such arrangements to the Recipient upon request.

  • Project Development a. Collaborate with COUNTY and project clients to identify requirements and develop a project Scope Statement. a. Develop a Work Breakdown Structure (WBS) for each project. b. Evaluate Scope Statement to develop a preliminary cost estimate and determinate whether project be vendor bid or be executed under a Job Order Contract (JOC).

  • Product Development (a) Supplier may develop enhancements it intends to incorporate into the BioGlue Surgical Adhesive during the term of this Agreement that have potential application to the Company Product (“Enhancements”). Unless otherwise agreed by the parties, at least once every six months during the Term, representatives of each of BioForm and Supplier shall hold a meeting in accordance with Sections 4.4 and 8.4 (the “Product Development Meeting”) at which Supplier will present Enhancements for BioForm to consider for application to the Company Product. At such Product Development Meeting, BioForm will also present its marketing plans (pursuant to Section 4.4) for the period and any information or feedback that BioForm reasonably believes may lead to Improvements. Within 30 calendar days following each Product Development Meeting, Supplier shall deliver a notice to BioForm (the “Enhancements Notice”) that shall describe the Enhancements that were presented by Supplier at such Product Development Meeting. Within 30 calendar days following receipt of the Enhancements Notice, BioForm may notify Supplier in writing if BioForm elects that any Enhancement described in the Enhancements Notice shall become an Improvement. If BioForm does provide such notice to Supplier during such 30-calendar day period, then BioForm and Supplier shall agree on a timeline for implementation of the Improvement in new Product Specifications for Company Product. If BioForm does not provide such a notice, said Enhancement shall not be implemented into the Company Product. The Enhancements Notice may also describe any potential Enhancements presented by Supplier at the Product Development Meeting, but BioForm shall not be required to take any action under this Section 8.4 with respect to such potential Enhancements until such time as they are presented by Supplier as Enhancements at a future Product Development Meeting. All Enhancements and potential Enhancement information provided by Supplier shall be considered Supplier Confidential Information. (b) From time to time, each party may request the other party to participate in joint projects to develop Improvements. Neither party is obligated to participate in such projects, and in each **** Certain information on this page has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. instance, each party’s decision whether to participate will be made in such party’s sole discretion. If both parties mutually agree to participate in such a project (a “Program”), the parties will promptly prepare a mutually agreeable written development agreement specifying the development activities to be performed by and the research and development tasks assigned to each party (the “Development Agreement”). All allocation of Intellectual Property rights with respect to any Program will be set forth in writing in the Development Agreement. (c) In the absence of a Development Agreement, (i) BioForm and Supplier shall retain joint ownership of Intellectual Property rights in which there is joint inventorship by BioForm (or its Affiliates) and Supplier, as determined in accordance with United States patent law, with Supplier’s rights in such joint ownership being subject to the license rights of BioForm under this Agreement, (ii) any Intellectual Property rights related to the Company Products, Enhancements, and Improvements that are created solely by employees or consultants of Supplier during the Term shall be considered to be Intellectual Property rights of Supplier, subject to the license rights of BioForm under this Agreement, and (iii) any Intellectual Property rights related to the Company Products and Improvements that are created solely by employees or consultants of BioForm or any of its Affiliates during the Term shall be considered to be Intellectual Property rights of BioForm. BioForm hereby grants to Supplier a perpetual, royalty free, world-wide, nonexclusive license to Supplier under such Blocking Intellectual Property to make, use, and sell such Intellectual Property outside the Field. “Blocking Intellectual Property” for the purposes of Section 8.4(c)(iii) shall mean Intellectual Property necessary for Supplier to make, use, or sell SA Product.

  • Non-Medical, Personalized Services The Practice shall also provide Members with the following non-medical services:

  • Information Systems Acquisition Development and Maintenance a. Client Data – Client Data will only be used by State Street for the purposes specified in this Agreement.

  • Research Primary Investigator as part of a multi-site study (25 points) • Co-Investigator as part of a multi-site study (20 points) • Primary Investigator of a facility/unit based research study (15 points) • Co-Investigator of a facility/unit based research study (10 points) • Develops a unit specific research proposal (5 points) • Conducts a literature review as part of a research study (5 points)

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!